Tekmira’s leading RNAi platform ready for prime time
February 23, 2010 by leonardzehr · Leave a Comment
As a global leader in the emerging field of RNA interference (RNAi), which holds the potential of revolutionizing medicine with new therapeutics, upstart Tekmira Pharmaceuticals (TSX:TKM) is at the precipice of confirming that the highly touted science works in humans. “We really are at the crux,” CEO Dr. Mark Murray says in an exclusive interview [...]
Listen to BioTuesdays 
